Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...
AHRQ’s PSNet provides access to patient safety resources, toolkits, opportunities for continuing education and trainings. The evidence reports are part of the agency’s Making Healthcare Safer Reports, ...